PRESS RELEASE published on 05/28/2024 at 14:30, 1 year 6 months ago Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea Napo Pharmaceuticals announces positive results from a study on crofelemer, a plant-based prescription drug, for functional diarrhea patients, showing reduced abdominal pain and improved stool consistency Napo Pharmaceuticals Crofelemer Functional Diarrhea Plant-based Prescription Drug Abdominal Pain
BRIEF published on 05/23/2024 at 14:35, 1 year 6 months ago Jaguar Health to Showcase Gelclair for Oral Mucositis at ASCO Annual Meeting Jaguar Health Gelclair Oral Mucositis Cancer Supportive Care ASCO Annual Meeting
BRIEF published on 05/23/2024 at 14:35, 1 year 6 months ago Jaguar Health présentera Gelclair pour le traitement de la mucite buccale lors de la réunion annuelle de l'ASCO Santé Jaguar Gelclair Mucite Buccale Soins De Soutien Contre Le Cancer Réunion Annuelle De L'ASCO
PRESS RELEASE published on 05/23/2024 at 14:30, 1 year 6 months ago Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product Jaguar Health, Inc. announces commercial launch at ASCO Annual Meeting for Gelclair, FDA-approved oral mucositis product. Focus on cancer supportive care with phase 3 OnTarget trial results impending Jaguar Health Phase 3 Trial Gelclair Oral Mucositis ASCO Annual Meeting
BRIEF published on 05/17/2024 at 22:20, 1 year 6 months ago Jaguar Health, Inc. Announces Reverse Stock Split Jaguar Health Inc Reverse Stock Split Nasdaq Compliance Institutional Investors Stock Adjustment
BRIEF published on 05/17/2024 at 22:20, 1 year 6 months ago Jaguar Health, Inc. annonce un regroupement d'actions Investisseurs Institutionnels Conformité NASDAQ Ajustement Des Stocks Regroupement Inversé Des Actions Jaguar Santé Inc.
PRESS RELEASE published on 05/17/2024 at 22:15, 1 year 6 months ago Jaguar Health, Inc. Announces Reverse Stock Split Jaguar Health announces reverse split approval at Special Meeting of Stockholders to boost Nasdaq compliance. Stock trading on split-adjusted basis from May 23, 2024. Details in SEC filing Stockholders Meeting Jaguar Health Nasdaq Compliance Reverse Split SEC Filing
BRIEF published on 05/14/2024 at 14:05, 1 year 6 months ago Jaguar Health Reports First Quarter 2024 Financial Results Financial Results Crofelemer Jaguar Health Q1 2024 Gelclair
BRIEF published on 05/14/2024 at 14:05, 1 year 6 months ago Jaguar Health publie ses résultats financiers du premier trimestre 2024 Résultats Financiers Crofelemer Santé Jaguar T1 2024 Gelclair
PRESS RELEASE published on 05/14/2024 at 14:00, 1 year 6 months ago Jaguar Health Reports First Quarter 2024 Financial Results Jaguar Health, Inc. reports Q1 2024 financial results, with revenue increasing 20% over Q1 2023. Key updates include OnTarget trial progress and Gelclair® commercial launch plans Financial Results Jaguar Health Q1 2024 OnTarget Trial Gelclair
Published on 12/06/2025 at 02:00, 2 hours 31 minutes ago Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 3 hours 16 minutes ago Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 4 hours 6 minutes ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 4 hours 31 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 5 hours 1 minute ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:15, 6 hours 15 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 6 hours 18 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 9 hours 32 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 10 hours 15 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 5 hours 31 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 5 hours 31 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 5 hours 31 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 5 hours 31 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 11 hours 13 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible